Anyone with significant medical conditions, anyone pregnant or breastfeeding, and anyone on multiple medications needs a careful review first not because problems are expected, but because limited human data means we don't assume
its safety and tolerability have not been fully clarified, and breakthroughs are still needed in production process optimization and raw material supply
Telehealth programs like this one do not examine the upstream genetic architecture that shapes every GLP-1 response
University of California, Davis, Department of Nutrition
doi:10.1210/clinem/dgae719 68
If you have been diagnosed with type 2 diabetes, your eligibility for GLP-1 medications is essentially guaranteed regardless of BMI, because these drugs were originally developed and approved for diabetes management